Users Manual Part 1

Clinical User’s Guide IBA | xxiii|
Volume 1 - Treatment Session
29. Radiation maculopathy after proton beam therapy for uveal melanoma: Optical
coherence tomography angiography alterations influencing visual acuity. Matet,
A, Daruich, A et Zografos, L. Lausanne : s.n., 2017, Investigative Ophtalmology
and Visual Science, Vol. 58, pp. 3851-3861.
30. Proton therapy of iris melanoma with 50 CGE. Riechardt, AI, et al. Berlin : s.n.,
2017, Strahlenther Onkol, pp. 943-950.
31. Dry eye syndrome after proton therapy of ocular melanomas. Thariat, J, et al. 1,
Nice : s.n., 2017, Int J Radiat Oncol Biol Phys, Vol. 98, pp. 142-151.
32. lntravitreal dexamethasone implant (Ozurdex) for exudative retinal detachment
after proton beam therapy for choroidal melanoma. Malclès, A, et al. Lyon : s.n.,
2017, European Journal of Ophtalmology, Vol. 27, pp. 596-600.
33. Technique, outcomes, and acute toxicities in adults treated with proton beam
craniospinal irradiation. Barney, CL, et al. Houston : s.n., 2014, Neuro-Oncology,
Vol. 16, pp. 303-309.
34. Proton beam craniospinal irradiation reduces acute toxicity for adults with
medulloblastoma. Brown, AP, et al. 2, Houston : s.n., 2013, Int J Radiat Oncol
Biol Phys, Vol. 86, pp. 277-284.
35. First experiences in treatment of low-grade glioma grade I and II with proton
therapy. Hauswald, H, et al. Heidelberg : s.n., 2012, Radiation Oncology.
36. Stereotactic proton beam therapy for intracranial arteriovenous malformations.
Vernimmen, FJ, et al. 1, Tygerberg : s.n., 2005, Int J Radiat Oncol Biol Phys, Vol.
62, pp. 44-52.
37. Clinical results of proton beam therapy for advanced neuroblastoma. Oshiro, Y,
et al. Tsukuba : s.n., 2013, Radiation Oncology.
38. Proton therapy for low-grade gliomas: Results from a prospective trial. Shih, HA,
et al. 2015, Cancer, pp. 1712-1719.
39. Phase I/II trial of hyperfractionated concomitant boost proton radiotherapy for
supratentorial glioblastoma multiforme. Mizumoto, M, et al. 1, Tsukuba : s.n.,
2010, Int J Radiat Oncol Biol Phys, Vol. 77, pp. 98-105.
40. Proton beam radiation therapy for skull base adenoid cystic carcinoma. Pommier,
P, et al. Boston : s.n., 2006, Arch Otolaryngol Head Neck Surg, Vol. 132, pp. 1242-
1249.
41. Spot scanning-based proton therapy for intracranial meningioma: Long-term
results from the Paul Scherrer Institute. Weber, DC, et al. 3, Geneva : s.n., 2011,
Int J Radiat Oncol Biol Phys, Vol. 83, pp. 865-871.
42. Long-term outcome of patients with spinal myxopapillary ependymoma:
treatment results from the MD Anderson Cancer Center and institutions from
the Rare Cancer Network. Weber, DC, et al. Villigen : s.n., 2015, Neuro-
Oncology, Vol. 17, pp. 588-595.
43. Proton beam radiation therapy results in significantly reduced toxicity compared
with intensity-modulated radiation therapy for head and neck tumors that require
ipsilateral radiation. Romesser, PB, et al. New York : s.n., 2016, Radiotherapy and
Oncology, Vol. 118, pp. 286-292.